Table 1.
Site | Patients/practices/clinicians | Men* | Age (years)† | Symptom severity†‡ | Oral temperature*§ | Comorbidity*¶ | Antibiotic treatment | Duration of course (days)† | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low | Normal | High | R | H | D | ||||||||
Belgium | |||||||||||||
Antwerp | 216/18/26 | 46.80 (101) | 47 (36-60) | 31 (21-40) | 19.70 (42) | 62.90 (134) | 17.40 (37) | 23.60 (51) | 8.30 (18) | 3.70 (8) | 25.90% (56) | 8 (7-8) | |
Finland | |||||||||||||
Helsinki | 103/2/26 | 24.30 (25) | 45 (34-56) | 31 (24-43) | 17.50 (18) | 76.70 (79) | 5.80 (6) | 13.60 (14) | 2.90 (3) | 2.90 (3) | 41.70% (43) | 9 (7-10) | |
Germany | |||||||||||||
Rotenberg | 229/16/16 | 31.00 (71) | 40 (29-52) | 33 (24-43) | 28.50 (65) | 65.40 (149) | 16.10 (14) | 15.30 (35) | 7.90 (18) | 4.40 (10) | 34.50% (79) | 7 (6-7) | |
Holland | |||||||||||||
Utrecht | 200/11/34 | 44 (88) | 57 (42-67) | 33 (24-43) | 28.50 (57) | 68.50 (137) | 3.00 (6) | 27.00 (54) | 15 (30) | 7.50 (15) | 41.50% (83) | 7 (7-7) | |
Hungary | |||||||||||||
Balatonfured | 323/11/11 | 39.90 (129) | 42 (29-53) | 26 (17-36) | 11.50 (37) | 51.10 (165) | 37.50 (121) | 9.30 (30) | 9.00 (29) | 4.00 (13) | 74.60% (241) | 5 (5-7) | |
Italy | |||||||||||||
Milan | 207/13/12 | 33.30 (69) | 43 (36-58) | 19 (12-29) | 13.50 (28) | 79.20 (164) | 7.20 (15) | 12.60 (26) | 7.20 (15) | 2.90 (6) | 74.90% (155) | 7 (5-7) | |
Norway | |||||||||||||
Tromso | 203/11/41 | 36.50 (74) | 50 (37-57) | 36 (26-43) | 21.40 (42) | 70.90 (139) | 7.70 (15) | 22.70 (46) | 7.40 (15) | 5.40 (11) | 30% (203) | 10 (7-10) | |
Poland | |||||||||||||
Lodz | 301/9/21 | 30.60 (92) | 40 (28-55) | 36 (26-45) | 33.20 (100) | 52.50 (158) | 14.30 (43) | 13.30 (40) | 19.90 (60) | 2.70 (8) | 71.40% (215) | 7 (5-7) | |
Slovakia | |||||||||||||
Bratislava | 299/5/23 | 33.10 (99) | 41 (30-52) | 26 (19-36) | 2.70 (8) | 71.80 (209) | 25.40 (74) | 13.00 (39) | 17.10 (51) | 3.30 (10) | 87.60% (262) | 7 (7-7) | |
Spain | |||||||||||||
Barcelona | 277/3/25 | 33.60 (93) | 43 (29-59) | 19 (14-29) | 20.70 (57) | 72.40 (199) | 6.90 (19) | 9.40 (26) | 3.60 (10) | 3.60 (10) | 20.60% (57) | 8 (6-8) | |
Mataro | 196/3/21 | 39.80 (78) | 46 (33-64) | 19 (13-29) | 24.50 (48) | 70.90 (139) | 4.60 (9) | 16.80 (33) | 10.20 (20) | 5.60 (11) | 34.20% (67) | 8 (5-8) | |
Sweden | |||||||||||||
Jonkoping | 300/12/81 | 36.70 (110) | 47.5 (37-61) | 38 (29-49) | 18.90 (56) | 70.70 (210) | 10.40 (31) | 16.00 (48) | 5.30 (16) | 3.30 (10) | 38% (114) | 9 (9-10) | |
UK | |||||||||||||
Cardiff | 300/5/26 | 38.30 (115) | 45 (34-59) | 36 (24-45) | 21.30 (64) | 74.30 (223) | 4.30 (13) | 26 (78) | 8.00 (24) | 5.00 (15) | 69.70% (209) | 7 (5-7) | |
Southampton | 214/6/23 | 39.30 (84) | 49 (36-59.75) | 36 (26-43) | 10.90 (23) | 82.50 (174) | 6.60 (14) | 20.60 (44) | 9.30 (20) | 3.70 (8) | 62.60% (214) | 7 (7-7) | |
Total | 3368/125/387 | 36.50 (1228/3368) | 45 (33-58) | 31 (19-40) | 19.30 (645) | 68.20 (2279) | 12.50 (417) | 15.30 (515) | 7.90 (266) | 4.10 (138) | 52.70% (1776) | 7 (6-7) |
*Percentage (number).
†Median (interquartile range).
‡Score scaled to range between 0 and 100.
§Low (<36°c), normal (≥36°c and ≤37.2°c), high (>37.2°c).
¶R=respiratory illness (chronic obstructive pulmonary disease (COPD), asthma, other lung disease); H=heart disease (heart failure, ischaemic heart disease, other heart disease); D=diabetes.